U.S. Leisure Stock News

Travel + Leisure (TNL) has just posted Q2 2026 results with revenue of US$1,063 million and basic EPS of US$1.75, alongside trailing twelve month revenue of US$4.1 billion and EPS of US$3.73 that give investors a broader read on the current earnings run rate. Over the last six reported quarters, revenue has ranged from US$934 million to US$1,063 million while quarterly basic EPS has moved between a loss of US$0.95 and a profit of US$1.75. This sets the stage for investors to weigh the latest...

IonQ stock has delivered a very strong 249.2% return over the past 5 years, yet its current valuation checks lean expensive and recent share price weakness raises questions about how much optimism is already in the price. IonQ has returned 249.2% over 5 years, which puts long term holders in a strong position but also raises the bar for what future fundamentals may need to support. Fresh research around using IonQ’s trapped ion systems to cut energy use in AI workloads can support long term...

Cal-Maine Foods (CALM) closed out FY 2026 with fourth quarter revenue of US$552.6 million and a quarterly loss of US$35.9 million, or EPS of US$0.76, against a backdrop of trailing 12 month EPS of US$6.65 on revenue of US$2.9 billion. Over recent quarters, the company has seen revenue move from US$1.4 billion in Q3 FY 2025 and EPS of US$10.42 to US$922.6 million and EPS of US$4.13 in Q1 FY 2026, before landing at the latest reported levels. With trailing net profit margin now sitting at 10.9%...

Pegasystems (PEGA) has reported Q2 2026 revenue of US$420.7 million with basic EPS of US$0.08, alongside trailing 12 month revenue of about US$1.74 billion and basic EPS of US$1.92 that sit against a 47.2% earnings growth rate over the past year. Over recent quarters the company has seen revenue range between US$381.4 million and US$504.3 million, while quarterly EPS has moved between US$0.18 and US$1.38. This sets up the latest print against a period of rising trailing net margins from 13.1%...

SPS Commerce stock has fallen a long way over the last few years, yet current valuation checks suggest the shares are no longer clearly mispriced and instead screen as roughly in line with fundamentals. Over the past 3 years, SPS Commerce has declined 65.6%, which puts recent trading squarely in the context of a prolonged drawdown. For a subscription based software business like SPS Commerce, the main support for valuation can come from durable recurring revenue and margins. A key risk is...

East West Bancorp (EWBC) opened Q2 2026 with total revenue of US$735.3 million and basic EPS of US$2.65, supported by net income of US$363.7 million. The company reported revenue of US$632.0 million and EPS of US$2.25 in Q2 2025, compared with US$735.3 million and EPS of US$2.65 in Q2 2026. Trailing 12 month EPS stands at US$10.46 on revenue of US$2.89 billion. These figures provide a basis for investors to examine how the company’s net interest margin and cost efficiency affect the...

Metropolitan Bank Holding (MCB) has just posted Q2 2026 results with revenue of US$79.7 million and basic EPS of US$1.55, alongside trailing twelve month revenue of US$312.0 million and EPS of US$7.98. Over recent quarters, revenue has moved from US$69.9 million in Q2 2025 to US$85.6 million in Q4 2025 and US$90.8 million in Q1 2026 before this latest print. Quarterly EPS has ranged from US$0.68 in Q3 2025 to US$2.94 in Q1 2026, which puts the focus on how efficiently those earnings are being...

Xcel Energy stock has delivered a 36.9% total return over the past 5 years, yet the valuation checks now suggest the shares may be leaning expensive. The Dividend Discount Model (DDM) intrinsic value estimate points to a premium over the current fundamentals, while the broader multiples reading appears closer to fair. A 36.9% return over 5 years puts Xcel Energy in the camp of steady compounders. This often leaves less room for investors seeking a clear discount to intrinsic...

The race to treat obesity and diabetes is shifting again after Eli Lilly pushed back approval plans for its next-generation obesity drug, retatrutide, to Q1 2027, even as phase 3 data showed weight loss of up to 22.6% and blood sugar benefits. This mix of regulatory delay and clinical progress can reshape expectations for companies exposed to these therapies. For investors, it creates a fresh reason to reassess risk, timing and potential rewards. The sections that follow break down how three...

Earlier in July 2026, LightPath Technologies announced an US$11 million follow-on purchase order from a global technology customer for infrared cameras used in counter‑UAS applications, reinforcing demand from public safety and defense markets. A series of historical shelf registration closures and withdrawals through July 22, 2026 also highlights how LightPath has periodically tapped and adjusted its access to equity capital over time, including offerings tied to employee stock ownership...

Valmont Industries has delivered a 118.6% total return over the past 5 years, yet its current valuation checks suggest the stock still trades at a discount to an estimate of intrinsic value based on a Discounted Cash Flow (DCF) approach and market multiples. Over 5 years, Valmont Industries has returned 118.6%. This puts the recent pullback into context as a long run of gains rather than a short-term story. Investor optimism around long-term utility and infrastructure demand can support...

AAR (AIR) has just posted FY 2026 results capped by fourth quarter revenue of US$928 million and basic EPS of US$1.29, against a backdrop of very large year over year reported earnings growth and a net profit margin that now sits at 5.7%. Over the past year the company has seen trailing twelve month revenue reach US$3.3 billion and EPS climb to US$4.90. Reported earnings growth of 1,401.6% reflects a sharp shift from the prior year’s base. For investors, this combination of higher earnings...

CME Group (CME) has just posted its Q2 2026 numbers with revenue of US$1,706.2 million and basic EPS of US$2.89, set against a trailing twelve month backdrop of US$6.76 billion in revenue and EPS of US$11.77. The company has seen quarterly revenue move between US$1,534.4 million and US$1,876.2 million over the last six reported periods, while basic EPS has ranged from US$2.49 to US$3.25, giving investors a clear read on earnings power heading into this latest update. With trailing net margins...

Union Pacific (NYSE:UNP) and Canadian National have signed a binding Memorandum of Understanding to expand cross border rail operating rights. The agreement is designed to improve freight flows between Canada, the US, and Mexico through key hubs such as Chicago and southern border gateways. The move focuses on more efficient rail connections for shippers using North American trade corridors. Union Pacific is a major freight railroad in the US, moving commodities, industrial goods, and...

Repligen (RGEN) has agreed to acquire BioLife Solutions in a roughly $1.5 billion deal, a move that immediately shifts investor focus to how a larger cell therapy footprint could influence the stock’s risk and reward profile. See our latest analysis for Repligen. Repligen’s share price has been volatile, with a 22.82% 90 day share price return and a 10.68% 30 day share price return contrasting with a decline of 14.76% year to date, while the 1 year total shareholder return of 19.60% hints at...

The quarterly results for Mercantile Bank Corporation ( NASDAQ:MBWM ) were released last week, making it a good time to...

American Tower stock has fallen 31.9% over the past five years, yet both its intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and its earnings multiples currently point to an undervalued setup compared with the market price. Over the last five years, American Tower has declined 31.9%, which puts recent pricing against a weak return backdrop for long term holders. Goldman Sachs initiating coverage with a Buy rating and a US$215 target highlights confidence in American...

MSCI (MSCI) has laid out a clean set of numbers for Q2 2026, with revenue at US$867 million and basic EPS of US$4.70, set against a trailing twelve month EPS of US$18.29 and total revenue of about US$3.3 billion that highlight the scale of the business. Over the last year, the company has seen revenue move from US$2.9 billion to about US$3.3 billion and EPS rise from US$14.58 to US$18.29, giving investors a clear view of the revenue and earnings trajectory feeding into this quarter's print...

Avista stock has delivered a 24.8% total return over the past three years, and at a recent price of US$42.23 the valuation picture is now mixed, with the Dividend Discount Model (DDM) suggesting a premium to its intrinsic value while market based multiples look closer to fair value. Over the last 3 years Avista has returned 24.8%. This puts more focus on whether that performance is already fully reflected in the current share price. For income focused investors, the stability of Avista's...

Fastenal stock has delivered an 88.3% return over the past five years, yet recent valuation checks and market multiples point to a setup where the shares may be pricing in a lot of good news already rather than offering an obvious bargain. Fastenal's 88.3% gain over five years highlights that long term holders have already seen substantial value creation, which can raise the bar for future returns from today's price. Ongoing investment in digital and inventory management services may support...

Penumbra (NYSE:PEN) reported key clinical results from its THUNDER study, indicating the THUNDERBOLT stroke treatment system met safety and effectiveness goals. The THUNDERBOLT system has now seen its first clinical use following recent FDA clearance, with initial adoption at a leading neuroscience institute. These updates add new clinical and real-world data points beyond prior announcements on the FORWARD study and regulatory clearance. For investors tracking Penumbra, the THUNDERBOLT...

We wouldn't blame Accelerant Holdings ( NYSE:ARX ) shareholders if they were a little worried about the fact that...

Over the last 7 days, the United States market has experienced a 1.4% drop, yet it remains up by 16% over the past year with earnings forecast to grow by 18% annually. In this context, identifying stocks that are potentially undervalued can be appealing for investors seeking opportunities in small-cap companies where insider buying might indicate confidence in future performance.

Over the last 7 days, the United States market has dropped 1.4%, but it remains up by 16% over the past year, with earnings expected to grow by 18% per annum in the coming years. In this dynamic environment, a good high-growth tech stock may be characterized by its potential for expansion and innovation, aligning well with current market conditions that favor robust earnings growth.